Fate Therapeutics, Inc.Fate Therapeutics, Inc.Fate Therapeutics, Inc.

Fate Therapeutics, Inc.

No trades
Buy FATE

FATE fundamentals

Fate Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of FATE for the last quarter is 6.77 M USD, and it's 251.79% higher compared to the previous quarter. The net income of Q2 24 is -38.43 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth